Annual Total Long Term Liabilities
$3.08 M
+$2.67 M+649.85%
December 31, 2023
Summary
- As of February 8, 2025, MLTX annual total long term liabilities is $3.08 million, with the most recent change of +$2.67 million (+649.85%) on December 31, 2023.
- During the last 3 years, MLTX annual total long term liabilities has risen by +$2.84 million (+1185.29%).
- MLTX annual total long term liabilities is now at all-time high.
Performance
MLTX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$2.63 M
+$66.50 K+2.59%
September 30, 2024
Summary
- As of February 8, 2025, MLTX quarterly total long term liabilities is $2.63 million, with the most recent change of +$66.50 thousand (+2.59%) on September 30, 2024.
- Over the past year, MLTX quarterly long term liabilities has increased by +$66.50 thousand (+2.59%).
- MLTX quarterly long term liabilities is now -14.68% below its all-time high of $3.08 million, reached on December 31, 2023.
Performance
MLTX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
MLTX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +649.9% | +2.6% |
| 3 y3 years | +1185.3% | +996.6% |
| 5 y5 years | +1185.3% | +996.6% |
MLTX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1185.3% | -14.7% | >+9999.0% |
| 5 y | 5-year | at high | +1185.3% | -14.7% | >+9999.0% |
| alltime | all time | at high | +1185.3% | -14.7% | >+9999.0% |
MoonLake Immunotherapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.63 M(+2.6%) |
| Jun 2024 | - | $2.56 M(-9.1%) |
| Mar 2024 | - | $2.82 M(-8.5%) |
| Dec 2023 | $3.08 M | $3.08 M(+1048.4%) |
| Sep 2023 | - | $268.50 K(-28.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $376.60 K(-7.1%) |
| Mar 2023 | - | $405.30 K(-1.4%) |
| Dec 2022 | $411.20 K(+71.4%) | $411.20 K(+8124.0%) |
| Sep 2022 | - | $5000.00(-73.1%) |
| Jun 2022 | - | $18.60 K(-92.2%) |
| Dec 2021 | $239.90 K | $239.90 K |
FAQ
- What is MoonLake Immunotherapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual total long term liabilities year-on-year change?
- What is MoonLake Immunotherapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly long term liabilities year-on-year change?
What is MoonLake Immunotherapeutics annual total long term liabilities?
The current annual total long term liabilities of MLTX is $3.08 M
What is the all time high annual total long term liabilities for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual total long term liabilities is $3.08 M
What is MoonLake Immunotherapeutics annual total long term liabilities year-on-year change?
Over the past year, MLTX annual total long term liabilities has changed by +$2.67 M (+649.85%)
What is MoonLake Immunotherapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of MLTX is $2.63 M
What is the all time high quarterly long term liabilities for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly total long term liabilities is $3.08 M
What is MoonLake Immunotherapeutics quarterly long term liabilities year-on-year change?
Over the past year, MLTX quarterly total long term liabilities has changed by +$66.50 K (+2.59%)